(Q51261778)

English

Oral spray immunization may be an alternative to intranasal vaccine delivery to induce systemic antibodies but not nasal mucosal or cellular immunity.

scientific article published in March 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 April 2018

http://europepmc.org/abstract/MED/16499576

Oral spray immunization may be an alternative to intranasal vaccine delivery to induce systemic antibodies but not nasal mucosal or cellular immunity. (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 April 2018

http://europepmc.org/abstract/MED/16499576

0 references

1 reference

based on heuristic

inferred from title

14

object named as

Rappuoli R

1 reference

Europe PubMed Central

PubMed publication ID

2 April 2018

http://europepmc.org/abstract/MED/16499576

author name string

Bakke H

1

1 reference

Europe PubMed Central

PubMed publication ID

2 April 2018

http://europepmc.org/abstract/MED/16499576

Samdal HH

2

1 reference

Europe PubMed Central

PubMed publication ID

2 April 2018

http://europepmc.org/abstract/MED/16499576

Holst J

3

1 reference

Europe PubMed Central

PubMed publication ID

2 April 2018

http://europepmc.org/abstract/MED/16499576

Oftung F

4

1 reference

Europe PubMed Central

PubMed publication ID

2 April 2018

http://europepmc.org/abstract/MED/16499576

Haugen IL

5

1 reference

Europe PubMed Central

PubMed publication ID

2 April 2018

http://europepmc.org/abstract/MED/16499576

Kristoffersen AC

6

1 reference

Europe PubMed Central

PubMed publication ID

2 April 2018

http://europepmc.org/abstract/MED/16499576

Haugan A

7

1 reference

Europe PubMed Central

PubMed publication ID

2 April 2018

http://europepmc.org/abstract/MED/16499576

Janakova L

8

1 reference

Europe PubMed Central

PubMed publication ID

2 April 2018

http://europepmc.org/abstract/MED/16499576

Korsvold GE

9

1 reference

Europe PubMed Central

PubMed publication ID

2 April 2018

http://europepmc.org/abstract/MED/16499576

Krogh G

10

1 reference

Europe PubMed Central

PubMed publication ID

2 April 2018

http://europepmc.org/abstract/MED/16499576

Andersen EA

11

1 reference

Europe PubMed Central

PubMed publication ID

2 April 2018

http://europepmc.org/abstract/MED/16499576

Djupesland P

12

1 reference

Europe PubMed Central

PubMed publication ID

2 April 2018

http://europepmc.org/abstract/MED/16499576

Holand T

13

1 reference

Europe PubMed Central

PubMed publication ID

2 April 2018

http://europepmc.org/abstract/MED/16499576

Haneberg B

15

1 reference

Europe PubMed Central

PubMed publication ID

2 April 2018

http://europepmc.org/abstract/MED/16499576

publication date

1 March 2006

1 reference

Europe PubMed Central

PubMed publication ID

2 April 2018

http://europepmc.org/abstract/MED/16499576

Scandinavian Journal of Immunology

1 reference

Europe PubMed Central

PubMed publication ID

2 April 2018

http://europepmc.org/abstract/MED/16499576

63

1 reference

Europe PubMed Central

PubMed publication ID

2 April 2018

http://europepmc.org/abstract/MED/16499576

3

1 reference

Europe PubMed Central

PubMed publication ID

2 April 2018

http://europepmc.org/abstract/MED/16499576

223-231

1 reference

Europe PubMed Central

PubMed publication ID

2 April 2018

http://europepmc.org/abstract/MED/16499576

Can nonliving nasal vaccines be made to work?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2006.01730.X

21 January 2018

Cold-adapted live influenza vaccine versus inactivated vaccine: systemic vaccine reactions, local and systemic antibody response, and vaccine efficacy. A meta-analysis.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2006.01730.X

21 January 2018

Immunoglobulin-A antibodies in upper airway secretions may inhibit intranasal influenza virus replication in mice but not protect against clinical illness

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2006.01730.X

21 January 2018

Influenza virus: immunity and vaccination strategies. Comparison of the immune response to inactivated and live, attenuated influenza vaccines

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2006.01730.X

21 January 2018

Cutting edge: the mucosal adjuvant cholera toxin redirects vaccine proteins into olfactory tissues

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2006.01730.X

21 January 2018

Outer membrane vesicles from group B meningococci are strongly immunogenic when given intranasally to mice.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2006.01730.X

21 January 2018

Inactivated meningococci and pertussis bacteria are immunogenic and act as mucosal adjuvants for a nasal inactivated influenza virus vaccine

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2006.01730.X

21 January 2018

Nasal immunization with subunit proteosome influenza vaccines induces serum HAI, mucosal IgA and protection against influenza challenge

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2006.01730.X

21 January 2018

A nasal Proteosome influenza vaccine containing baculovirus-derived hemagglutinin induces protective mucosal and systemic immunity.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2006.01730.X

21 January 2018

Role of secretory antibodies in the defence against infections

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2006.01730.X

21 January 2018

Bi-directional nasal delivery of aerosols can prevent lung deposition.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2006.01730.X

21 January 2018

Effects of sample processing on the measurement of specific intestinal IgA immune responses

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2006.01730.X

21 January 2018

Granzyme B ELISPOT assay for ex vivo measurements of T cell immunity

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2006.01730.X

21 January 2018

A novel cytotoxicity assay to evaluate antigen-specific CTL responses using a colorimetric substrate for Granzyme B

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2006.01730.X

21 January 2018

Protective levels of diphtheria-neutralizing antibody induced in healthy volunteers by unilateral priming-boosting intranasal immunization associated with restricted ipsilateral mucosal secretory immunoglobulin a

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2006.01730.X

21 January 2018

Regional induction of adhesion molecules and chemokine receptors explains disparate homing of human B cells to systemic and mucosal effector sites: dispersion from tonsils

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2006.01730.X

21 January 2018

A quantitative analysis of the intranasal delivery of topical nasal drugs to the middle meatus: spray versus drop administration.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2006.01730.X

21 January 2018

The assessment of topical nasal drug distribution

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2006.01730.X

21 January 2018

Immunisation schedules for non-replicating nasal vaccines can be made simple by allowing time for development of immunological memory

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2006.01730.X

21 January 2018

Identifiers

10.1111/J.1365-3083.2006.01730.X

1 reference

Europe PubMed Central

PubMed publication ID

2 April 2018

http://europepmc.org/abstract/MED/16499576

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 April 2018

http://europepmc.org/abstract/MED/16499576

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51261778&oldid=1246334035"